SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $488,757 | -73.2% | 65,605 | -73.5% | 0.11% | -56.4% |
| Q2 2020 | $1,821,004 | +85.8% | 247,419 | +86.8% | 0.25% | +2.5% |
| Q1 2020 | $979,901 | -42.6% | 132,419 | -56.1% | 0.24% | -18.9% |
| Q4 2019 | $1,707,260 | +31.2% | 301,636 | +36.1% | 0.30% | -25.5% |
| Q3 2019 | $1,301,003 | +134.0% | 221,636 | +27.2% | 0.40% | +159.0% |
| Q2 2019 | $556,007 | – | 174,297 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |